368 related articles for article (PubMed ID: 16415090)
1. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
2. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
3. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
4. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
Zong J; Pollack GM
J Pharmacol Exp Ther; 2003 Aug; 306(2):556-62. PubMed ID: 12721332
[TBL] [Abstract][Full Text] [Related]
5. P glycoprotein regulated transport of glutamate at blood brain barrier.
Liu XD; Liu GQ
Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
Yang ZH; Liu XD
Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
[TBL] [Abstract][Full Text] [Related]
7. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
Chikhale EG; Burton PS; Borchardt RT
J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780
[TBL] [Abstract][Full Text] [Related]
8. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
[TBL] [Abstract][Full Text] [Related]
9. Predicting the outer boundaries of P-glycoprotein (P-gp)-based drug interactions at the human blood-brain barrier based on rat studies.
Hsiao P; Unadkat JD
Mol Pharm; 2014 Feb; 11(2):436-44. PubMed ID: 24364805
[TBL] [Abstract][Full Text] [Related]
10. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
Ejsing TB; Linnet K
Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
[TBL] [Abstract][Full Text] [Related]
11. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.
Sasongko L; Link JM; Muzi M; Mankoff DA; Yang X; Collier AC; Shoner SC; Unadkat JD
Clin Pharmacol Ther; 2005 Jun; 77(6):503-14. PubMed ID: 15961982
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
Tsai PL; Tsai TH
Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
[TBL] [Abstract][Full Text] [Related]
13. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier.
Syvänen S; Hooker A; Rahman O; Wilking H; Blomquist G; Långström B; Bergström M; Hammarlund-Udenaes M
J Pharm Sci; 2008 Dec; 97(12):5386-400. PubMed ID: 18384156
[TBL] [Abstract][Full Text] [Related]
15. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments.
Yang ZH; Sun X; Qi Y; Mei C; Sun XB; Du GH
J Asian Nat Prod Res; 2012; 14(1):14-21. PubMed ID: 22263589
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil.
Marier JF; Deschênes JL; Hage A; Seliniotakis E; Gritsas A; Flarakos T; Beaudry F; Vachon P
Life Sci; 2005 Oct; 77(23):2911-26. PubMed ID: 15964599
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein restricted transport of nimodipine across blood-brain barrier.
Zhang L; Liu XD; Xie L; Wang GJ
Acta Pharmacol Sin; 2003 Sep; 24(9):903-6. PubMed ID: 12956939
[TBL] [Abstract][Full Text] [Related]
18. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
19. Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation.
Fang W; Lv P; Geng X; Shang E; Yang Q; Sha L; Li Y
Neurochem Int; 2013 Jan; 62(1):23-30. PubMed ID: 23142723
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
He L; Zhao C; Yan M; Zhang LY; Xia YZ
Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
